Systematic evaluation of structure-activity relationships of the riminophenazine class and discovery of a C2 pyridylamino series for the treatment of multidrug-resistant tuberculosis

Molecules

Volumn 17, Issue 4, 2012, Pages 4545-4559

  Liu, Binna ^a   Liu, Kai ^b   Lu, Yu ^a   Zhang, Dongfeng ^a   Yang, Tianming ^a   Li, Xuan ^a   Ma, Chen ^a   Zheng, Meiqin ^b   Wang, Bin ^b   Zhang, Gang ^a   Wang, Fei ^a   Ma, Zhenkun ^c   Li, Chun ^a   Huang, Haihong ^a   Yin, Dali ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT   (United States)

Author keywords

Anti tuberculosis; Clofazimine; MDR TB; Riminophenazine; Skin pigmentation

Indexed keywords

CLOFAZIMINE; DRUG DERIVATIVE; TUBERCULOSTATIC AGENT;

ARTICLE; CHEMISTRY; DRUG EFFECT; HUMAN; MICROBIOLOGICAL EXAMINATION; MYCOBACTERIUM TUBERCULOSIS; STRUCTURE ACTIVITY RELATION;

ANTITUBERCULAR AGENTS; CLOFAZIMINE; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84860230396     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules17044545     Document Type: Article

References (9)

1. World Health Organization (WHO). Global Tuberculosis Control 2009: Epidemiology, Strategy, Financing; WHO: Geneva, Swizerland, 2009.
2. Chan, E.D.; Iseman, M.D. Current medical treatment for tuberculosis. Br. Med. J. 2002, 325, 1282-1286.
3. Perri, G.D.; Bonora, S. Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis? J. Antimicrob. Chemother. 2004, 54, 593-602.
4. Barry, V.C.; Buggle, K. Absorption, distribution and retention of the riminocompounds in the experimental animal. Ir. J. Med. Sci. 1960, 416, 345-352.
5. Barry, V.C.; Conalty, M.L. The antimycobacterial activity of B663. Lepr. Rev. 1965, 36, 3-7.
6. Reddy, V.M.; Nadadhur, G. Antituberculosis activities of clofazimine and its new analogs B4154 and B4157. Antimicrob. Agents Chemother. 1996, 40, 633-636.
7. Reddy, V.M.; O'Sullivan, J.F.; Gangadharam, P.R. Antimycobacterial activities of riminophenazines. J. Antimicrob. Chemother. 1999, 43, 615-623.
8. O'Connor, R.; O'Sullivan, J.F. The pharmacology, metabolism, and chemistry of clofazimine Drug Metab. Rev. 1995, 27, 591-614.
9. Lu, Y.; Zheng, M.; Wang, B. Clofazimine analogs with efficacy against experimental tuberculosis and reduced potential for accumulation. Antimicrob. Agents Chemother. 2011, 55, 5185-5193.